期刊文献+

COPD合并勃起功能障碍的调查研究 被引量:5

Investigation of erectile dysfunction in patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的研究COPD患者合并勃起功能障碍(ED)的发生率。方法对顺序纳入2010年7月~2012年7月宁德市医院门诊就诊的符合入选标准的男性COPD稳定期患者86例进行临床评估,年龄44~70岁,平均(62.28±6.44)岁;同时选取相匹配的对照组30名。所有受试者均进行肺功能测定[包括用力肺活量(FVC%)、第一秒用力呼气容积(FEV1%)、一秒率(FEV1/FVC%)和一氧化碳弥散量(DLco%)]、6分钟步行试验(6MWT)、指端血氧饱和度测定(SaO2)和血清性激素[血清睾酮(T)和雌二醇(E2)水平]检测,同时通过回答国际勃起功能指数-5(IIEF-5)问卷来诊断和评估ED。结果 COPD组总的ED发病率70%,对照组67%。与对照组相比,COPD组血清睾酮水平明显降低[分别为(4.63±1.70)和(3.57±1.52)],而血清雌二醇水平差别无统计学差异[分别为(25.45±8.35)和(22.95±6.17)]。相比对照组,COPD组中、重度ED的发生率更高[分别为14%和42%],并且ED的分值更低、程度更重[ED分值分别为(17.91±7.90)和(12.66±8.44);ED程度值分别为(2.53±1.49)和(1.66±0.71)]。COPD组ED的分值与年龄无相关性,但与吸烟、病程、6MWD、FEV1%、DLco、SaO2、T指标相关,且均有统计学意义。结论 COPD患者较同年龄的健康对照组ED的发生更加频繁且严重,对COPD综合评估和管理时应引起重视。 Objective To investigate the erectile dysfunction in patients with COPD. Methods 86 male patients with COPD were selected in this study, aging from 44 to 70 years old, with an average of 62. 28 ± 6. 44. 30 healthy people were taken as controls. Their lung function were detected, including FVC%, FEV1%, FEV1/FVC%, DLco%, 6MWT, SaO2 and T and E2. They were asked to answer the International Index of Erectile Func-tion 5 (IIEF-5) questionnaire as a method to diagnose and classify ED. Results The serum level of testosterone in the COPD group was lower than that in the control group, but the serum level of estradiol showed no significant differ-ence between the two groups. The incidence of ED was obviously higher in the patients with moderate and severe COPD than others. The score of ED of COPD patients was not correlated with age and estradiol levels, but correlated with smoking burden, duration of COPD, FEV1%, DLco, SaO2, 6MWD and testosterone level. Conclusion The present study shows that ED is frequent and more severe in COPD patients than age-matched controls. Patients with COPD need comprehensive management including a detailed sexual evaluation.
出处 《临床肺科杂志》 2014年第9期1572-1575,共4页 Journal of Clinical Pulmonary Medicine
基金 福建省宁德市科委立项课题(No 3522D0901)
关键词 慢性阻塞性肺疾病 国际勃起功能指数量表 勃起功能障碍 性功能 睾酮 pulmonary disease chronic obstructive IIEF-5 erectile dysfunction sexuality testosterone
  • 相关文献

参考文献20

  • 1ATS Committee on Proficiency Standards for Clinical Pulmonary- Function Laboratories. ATS statement: guidelines for the six-mi- nute walk test[ J]. Am J Respir Crit Care Med,2002,166 ( 1 ) : 111 -117.
  • 2朱积川,许清泉.男性性功能障碍诊治框架[J].中华男科学杂志,2005,11(9):713-715. 被引量:16
  • 3朱积川.男子勃起功能障碍诊治指南[J].中国男科学杂志,2004,18(1):68-72. 被引量:115
  • 4Feldman HA, Goldstein I, Hatzichristou D, et al. Impotence and its medical and psychological correlates: results of the Massachu-setts male aging study[J]. J Urol, 1994, 151:54 -61.
  • 5Akkus E, Kadyoglu A, Esen A, et al. Turkish erectile dysfunc- tion prevalence study group: Prevalence and correlates of erectile dysfunction in Turkey : a population based study [ J ]. Eur Urol, 2002, 41:298 - 304.
  • 6蔡柏蔷.应重视慢性阻塞性肺疾病的合并症问题[J].中华结核和呼吸杂志,2013,36(4):245-247. 被引量:37
  • 7Koseoglu N, Koseoglu H, Ceylan E, et al. Erectile dysfunction prevalence and sexual function status in patient with chronic ob- structive pulmonary disease[ J]. J Urol, 2005, 174:249 -252.
  • 8Karadag F, Ozcan H, Karul AB, et al. Correlates of erectile dys- function in moderate-to-severe chronic obstructive pulmonary dis- ease patients[ J]. Respirology, 2007,12:248 - 253.
  • 9Collins EG, Halabi S, Langston M, et al. Sexual dysfunction in men with COPD: impact on quality of life and survival[J]. Lung, 2012, 190:545-556.
  • 10Usalan AK, Polat G, Bilyiik. irin M, et al. The relation between erectile dysfunction and disease parameters in COPD[ J ]. Turkish J Geriatrics, 2011, 14:238 -244.

二级参考文献13

  • 1Lue TF, Giuliano F, Montorsi F, et al. Summary of the Recommendations on Sexual Dysfunctions in Men[J]. J Sexual Medicine, 2004, 1(1):6-22.
  • 2Sethi S. Infection as a comorbidity of COPD. Eur Respir J, 2010, 35 : 1209-1215.
  • 3GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Revised 2011 ) [ EB/OL. [2013-01-10]. http:// www. goldcopd, com.
  • 4AgustiA, Faner R. Systemic chronic obstructive pulmonary inflammation and comorbidities in disease. Proc Am Thorac Soc, 2012, 9: 43-46.
  • 5Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J, 2009, 33 : 1165-1185.
  • 6Sinden N J, Stockley RA. Systemic ifflammation and comorbidity in COPD : a result of ' overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax, 2010, 65 : 930-936.
  • 7Corsonello A, Antonelli Incalzi R, Pistelli R, et al. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2011, 17 Suppl 1 : S21-S28.
  • 8Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14. 5-year mortality : a randomized clinical trial. Ann Intern Med, 2005, 142: 233-239.
  • 9Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 2007, 356: 775-789.
  • 10Ohara T, Hirai T, Muro S, et al. Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest, 2008, 134: 1244-1249.

共引文献168

同被引文献72

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部